Click here to close now.




















Welcome!

News Feed Item

Nutricia Launches Breakthrough Once-a-Day Drink for People with Early Alzheimer's Disease

LONDON, January 14, 2013 /PRNewswire/ --

Souvenaid, a "Food for Special Medical Purposes" for the dietary management of early Alzheimer's disease

From today, Souvenaid, a unique 125ml once-a-day drink, is available for people living with early Alzheimer's disease. This over-the-counter innovative product is the result of over 10 years' research into the nutritional needs of people living with the early stages of the disease.

     (Logo: http://photos.prnewswire.com/prnh/20130113/588426 )

Around 800,000 people in the UK live with dementia,1 of which Alzheimer's disease is the most common form. It is a growing health problem in an aging population, leading the government to prioritise earlier diagnosis of the condition.

The loss of connections in the brain (synapses) is one of the key features of early Alzheimer's disease. A combination of nutrients are required in the process of making new connections and people living with Alzheimer's disease have been shown to have relatively low levels of these nutrients in their bodies despite eating a normal diet.2,3,4,5,6,7

This adds to a growing body of evidence that highlights how nutrition can help manage the disease in the early stages.8,9,10,11,12,13

Dr David Wilkinson, Consultant in Old Age Psychiatry, commented: "Alzheimer's disease is not part and parcel of aging but a serious and progressive disease of the brain which prevents us from being able to retain new memories. As we age, our bodies become less efficient at processing essential nutrients, meaning that we need to increase our intake of food to absorb the same amount of nutrients in order to maintain a healthy body. In the same way, we need the right nutrients for our brains to keep them healthy.

"Alzheimer's disease sufferers often find it very difficult to get everything they need through diet alone and the nutritional intervention by the use of Souvenaid is a new area of research offering promising results for the management of early Alzheimer's disease."

The current healthcare provision for people with early Alzheimer's disease fails to reflect the important role that nutrition can play in managing the disease. A recent survey of specialists involved in the diagnosis of Alzheimer's disease showed that only a third (33%) regularly assess patients' nutritional status during the diagnostic process.14 Two-thirds of specialists do not even have access to a dietician for these patients.14

Often, after a diagnosis of Alzheimer's disease, it can be difficult to stay positive, particularly when there is little to offer in the way of effective early interventions. Souvenaid offers a new option for people living with early-stage Alzheimer's disease.

Barbara Stephens, Dementia UK Chief Executive, commented: "A diagnosis of dementia is devastating both for those with the condition and their families and carers. Early-stage intervention is important for maximising choices and enabling people with dementia and their carers to lead healthier lives for longer." 

Souvenaid contains a unique combination of nutrients that are naturally present in food, at levels difficult to achieve from diet alone. It contains: omega-3 polyunsaturated fatty acids (docosahexaenoic acid (DHA), eicosapentaenoic acid [EPA]), uridine (as uridine monophosphate [UMP]) and choline, together with phospholipids and B vitamins. Souvenaid comes in two tasty flavours (vanilla and strawberry) and tastes best served chilled. Souvenaid is designed to be incorporated into the daily routine, for example, by taking it at breakfast time.

Souvenaid is a Food for Special Medical Purposes, for the dietary management of early Alzheimer's disease. It is available over-the-counter from local accredited pharmacists. People with early Alzheimer's disease must speak with a doctor, specialist nurse, dietician or pharmacist to see if Souvenaid is right for them.

Please visit http://www.souvenaid.com for more information.

Notes to Editors

About Nutricia Advanced Medical Nutrition

  • Nutricia is the leading medical nutrition company in Europe. It is part of Danone, one of the fastest-growing food and nutrition companies in the world.
  • Nutricia aims to bring health through medical nutrition to those people who most need it, focusing on people with disease- or age-related nutritional needs.
  • Nutricia has an extensive portfolio of products and services, catering from nutritional needs in metabolic conditions such as phenylketonuria (PKU), to non-metabolic conditions such as allergy and epilepsy, to disease-related malnutrition and frailty.
  • Through its Homeward service and 100 dedicated nurses, Nutricia supports over 20,000 people in the UK who require enteral nutrition (tube feeding) support in their own homes.

http://www.nutricia.com

About Souvenaid

Souvenaid is:

  • Designed to be taken daily.
  • A 125ml daily drink, available in two tasty flavours, vanilla and strawberry.
  • A food for special medical purposes and must be used under medical supervision.
  • Available from 14th January 2013 in accredited pharmacies in England, Wales and Scotland, and via http://www.souvenaid.com.
  • Gluten and lactose free.

Souvenaid contains:

  • A unique combination of nutrients including omega-3 polyunsaturated fatty acids (docosahexaenoic acid, DHA and eicosapentaenoic acid (EPA)), uridine (as uridine monophosphate (UMP)) and choline, together with phospholipids and B vitamins. Whilst such nutrients are naturally present in food, such levels are difficult to achieve from diet alone.

The safety and efficacy of Souvenaid has been studied in several clinical trials.7,15,16 A further study in prodromal (non-symptomatic Alzheimer's disease) is currently underway. This trial is wholly funded by the European Union.17

Please visit http://www.souvenaid.com for more information.

References

1. Alzheimer's Society. Statistics [Online] http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=341 [Accessed December 2012].

2. Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010;5:45-61.

3. Smach MA, Jacob N, Golmard J-L et al. Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur. Neurol. 2011;65(5):270-8.

4. Glasø M, Nordbø G, Diep L, Bøhmer T. Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J Nutr Health Aging. 2004;8(5):407-13.

5. Lopes da Silva S, Elemans S et al. Plasma nutrient status of Alzheimer's disease patients compared to cognitive intact elderly controls; a systematic review and meta-analysis. Alzheimers Dement 2012; 8(4):Supple 2 216.

6. Sijben J, Olde Rikkert MG et al. Different nutritional status in patients with mild Alzheimer's disease compared to healthy controls. Eur J Neurol 2012; in press.

7. Scheltens P, Twisk JW, Blesa R et al. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J  Alzheimers Dis. 2012; 31:225-36.

8. Morris MC, Evans DA, Bienias JL et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 2003; 60(7):940-6.

9. Sydenham E, Dangour AD, Lim W-S. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012; 6:CD005379.

10. Gu Y, Nieves JW, Stern Y et al. Food combination and Alzheimer disease risk: a protective diet. Arch. Neurol. 2010; 67(6):699-706.

11. Zandi PP, Anthony JC, Khachaturian AS et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 2004; 61(1):82-8.

12. Quadri P, Fragiacomo C, Pezzati R et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 2004; 80(1):114-122.

13. Sachdev PS. Homocysteine and brain atrophy. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005; 29(7):1152-1161.

14. 100 specialists were surveyed online. Fieldwork was conducted by MedeConnect Healthcare Insight 2-16 November 2012.

15. Scheltens P, Kamphuis PJ, Verhey F et al. Efficacy of a medical food in mild Alzheimer's Disease: a randomized controlled trial.

Alzheimer's & Dementia. 2010;6:1-10.

16. Shah R et al. Souvenaid® as an add-on intervention in patients with mild to moderate Alzheimer's disease using Alzheimer's disease medication: results from a randomized, controlled, double-blind study (S-Connect). CTAD, San Diego, November 2011; J Nutr Health Aging (Nov suppl.).

17. European Commission website. LipiDiDiet: http:ec.europa.eu/research/bioeconomy/lipidiet_en.htm [Accessed December 2012].

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
IBM’s Blue Box Cloud, powered by OpenStack, is now available in any of IBM’s globally integrated cloud data centers running SoftLayer infrastructure. Less than 90 days after its acquisition of Blue Box, IBM has integrated its Blue Box Cloud Dedicated private-cloud-as-a-service into its broader portfolio of OpenStack® based solutions. The announcement, made today at the OpenStack Silicon Valley event, further highlights IBM’s continued support to deliver OpenStack solutions across all cloud depl...
SYS-CON Events announced today that Pythian, a global IT services company specializing in helping companies leverage disruptive technologies to optimize revenue-generating systems, has been named “Bronze Sponsor” of SYS-CON's 17th Cloud Expo, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Founded in 1997, Pythian is a global IT services company that helps companies compete by adopting disruptive technologies such as cloud, Big Data, advance...
Consumer IoT applications provide data about the user that just doesn’t exist in traditional PC or mobile web applications. This rich data, or “context,” enables the highly personalized consumer experiences that characterize many consumer IoT apps. This same data is also providing brands with unprecedented insight into how their connected products are being used, while, at the same time, powering highly targeted engagement and marketing opportunities. In his session at @ThingsExpo, Nathan Trel...
While many app developers are comfortable building apps for the smartphone, there is a whole new world out there. In his session at @ThingsExpo, Narayan Sainaney, Co-founder and CTO of Mojio, will discuss how the business case for connected car apps is growing and, with open platform companies having already done the heavy lifting, there really is no barrier to entry.
WebRTC has had a real tough three or four years, and so have those working with it. Only a few short years ago, the development world were excited about WebRTC and proclaiming how awesome it was. You might have played with the technology a couple of years ago, only to find the extra infrastructure requirements were painful to implement and poorly documented. This probably left a bitter taste in your mouth, especially when things went wrong.
SYS-CON Events announced today that HPM Networks will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. For 20 years, HPM Networks has been integrating technology solutions that solve complex business challenges. HPM Networks has designed solutions for both SMB and enterprise customers throughout the San Francisco Bay Area.
SYS-CON Events announced today that G2G3 will exhibit at SYS-CON's @DevOpsSummit Silicon Valley, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Based on a collective appreciation for user experience, design, and technology, G2G3 is uniquely qualified and motivated to redefine how organizations and people engage in an increasingly digital world.
SYS-CON Events announced today the Containers & Microservices Bootcamp, being held November 3-4, 2015, in conjunction with 17th Cloud Expo, @ThingsExpo, and @DevOpsSummit at the Santa Clara Convention Center in Santa Clara, CA. This is your chance to get started with the latest technology in the industry. Combined with real-world scenarios and use cases, the Containers and Microservices Bootcamp, led by Janakiram MSV, a Microsoft Regional Director, will include presentations as well as hands-on...
Through WebRTC, audio and video communications are being embedded more easily than ever into applications, helping carriers, enterprises and independent software vendors deliver greater functionality to their end users. With today’s business world increasingly focused on outcomes, users’ growing calls for ease of use, and businesses craving smarter, tighter integration, what’s the next step in delivering a richer, more immersive experience? That richer, more fully integrated experience comes ab...
SYS-CON Events announced today that Micron Technology, Inc., a global leader in advanced semiconductor systems, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Micron’s broad portfolio of high-performance memory technologies – including DRAM, NAND and NOR Flash – is the basis for solid state drives, modules, multichip packages and other system solutions. Backed by more than 35 years of tech...
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
In today's digital world, change is the one constant. Disruptive innovations like cloud, mobility, social media, and the Internet of Things have reshaped the market and set new standards in customer expectations. To remain competitive, businesses must tap the potential of emerging technologies and markets through the rapid release of new products and services. However, the rigid and siloed structures of traditional IT platforms and processes are slowing them down – resulting in lengthy delivery ...
As more intelligent IoT applications shift into gear, they’re merging into the ever-increasing traffic flow of the Internet. It won’t be long before we experience bottlenecks, as IoT traffic peaks during rush hours. Organizations that are unprepared will find themselves by the side of the road unable to cross back into the fast lane. As billions of new devices begin to communicate and exchange data – will your infrastructure be scalable enough to handle this new interconnected world?
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, discussed why containers should be paired with new architectural practices such as microservices rathe...
U.S. companies are desperately trying to recruit and hire skilled software engineers and developers, but there is simply not enough quality talent to go around. Tiempo Development is a nearshore software development company. Our headquarters are in AZ, but we are a pioneer and leader in outsourcing to Mexico, based on our three software development centers there. We have a proven process and we are experts at providing our customers with powerful solutions. We transform ideas into reality.